A detailed history of Altrius Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Altrius Capital Management Inc holds 97,662 shares of BMY stock, worth $5.63 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
97,662
Previous 97,042 0.64%
Holding current value
$5.63 Million
Previous $4.03 Million 25.41%
% of portfolio
1.3%
Previous 1.08%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$39.66 - $51.75 $24,589 - $32,085
620 Added 0.64%
97,662 $5.05 Million
Q2 2024

Aug 12, 2024

BUY
$40.25 - $52.99 $809,025 - $1.07 Million
20,100 Added 26.12%
97,042 $4.03 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $389,117 - $441,184
8,110 Added 11.78%
76,942 $4.17 Million
Q4 2023

Feb 05, 2024

BUY
$48.48 - $57.85 $712,171 - $849,816
14,690 Added 27.13%
68,832 $3.53 Million
Q3 2023

Oct 30, 2023

BUY
$57.89 - $64.73 $436,085 - $487,611
7,533 Added 16.16%
54,142 $3.14 Million
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $113,722 - $126,270
1,785 Added 3.98%
46,609 $2.98 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $204,226 - $231,639
3,108 Added 7.45%
44,824 $3.11 Million
Q4 2022

Feb 07, 2023

SELL
$68.48 - $81.09 $90,736 - $107,444
-1,325 Reduced 3.08%
41,716 $3 Million
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $3,249 - $1.92 Million
-24,998 Reduced 36.74%
43,041 $3.06 Million
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $4.94 Million - $5.44 Million
68,039 New
68,039 $5.24 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Altrius Capital Management Inc Portfolio

Follow Altrius Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrius Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altrius Capital Management Inc with notifications on news.